Annual Cash & Cash Equivalents
$11.99 M
+$6.74 M+128.28%
December 1, 2023
Summary
- As of March 8, 2025, REVB annual cash & cash equivalents is $11.99 million, with the most recent change of +$6.74 million (+128.28%) on December 1, 2023.
- During the last 3 years, REVB annual cash & cash equivalents has risen by +$7.50 million (+166.93%).
- REVB annual cash & cash equivalents is now at all-time high.
Performance
REVB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.54 M
-$5.53 M-45.82%
September 1, 2024
Summary
- As of March 8, 2025, REVB quarterly cash and cash equivalents is $6.54 million, with the most recent change of -$5.53 million (-45.82%) on September 1, 2024.
- Over the past year, REVB quarterly cash and cash equivalents has stayed the same.
- REVB quarterly cash and cash equivalents is now -63.05% below its all-time high of $17.70 million, reached on March 31, 2023.
Performance
REVB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
REVB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +128.3% | 0.0% |
| 3 y3 years | +166.9% | 0.0% |
| 5 y5 years | - | 0.0% |
REVB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +840.8% | -63.0% | +413.1% |
| 5 y | 5-year | at high | +840.8% | -63.0% | +413.1% |
| alltime | all time | at high | +840.8% | -63.0% | +413.1% |
Revelation Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.54 M(-45.8%) |
| Jun 2024 | - | $12.07 M(-17.0%) |
| Mar 2024 | - | $14.55 M(+21.3%) |
| Dec 2023 | $11.99 M(+128.3%) | $11.99 M(-14.3%) |
| Sep 2023 | - | $13.99 M(-10.9%) |
| Jun 2023 | - | $15.71 M(-11.3%) |
| Mar 2023 | - | $17.70 M(+237.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $5.25 M(+312.1%) | $5.25 M(-15.2%) |
| Sep 2022 | - | $6.20 M(+78.2%) |
| Jun 2022 | - | $3.48 M(-51.6%) |
| Mar 2022 | - | $7.19 M(+463.8%) |
| Dec 2021 | $1.27 M(-71.6%) | $1.27 M(-69.2%) |
| Sep 2021 | - | $4.14 M |
| Dec 2020 | $4.49 M | - |
FAQ
- What is Revelation Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Revelation Biosciences?
- What is Revelation Biosciences annual cash & cash equivalents year-on-year change?
- What is Revelation Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Revelation Biosciences?
- What is Revelation Biosciences quarterly cash and cash equivalents year-on-year change?
What is Revelation Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of REVB is $11.99 M
What is the all time high annual cash & cash equivalents for Revelation Biosciences?
Revelation Biosciences all-time high annual cash & cash equivalents is $11.99 M
What is Revelation Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, REVB annual cash & cash equivalents has changed by +$6.74 M (+128.28%)
What is Revelation Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of REVB is $6.54 M
What is the all time high quarterly cash and cash equivalents for Revelation Biosciences?
Revelation Biosciences all-time high quarterly cash and cash equivalents is $17.70 M
What is Revelation Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, REVB quarterly cash and cash equivalents has changed by $0.00 (0.00%)